1. Market Research
  2. > Therapy Industry

Chemotherapy Industry, December 2016 Market Reports from Top Publishers

You might be interested in: Therapy, Cancer, Colorectal Cancer, Breast Cancer, Pump, Lung Cancer, Lymphoma, Prostate Cancer, Brain Cancer, Targeted Therapy, Gastric Cancer, Hormone, Biosimilar, Bladder Cancer, Blood Disease, Pancreatic Cancer, Anti-Infective, Cervical Cancer, Digestive System Disorder, Erythropoietin.


 
1-10 of about 500 reports for Chemotherapy

Purchase Reports From Reputable Market Research Publishers

Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by Global Data

Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" ...

Oncology drug report - Herceptin - trastuzumab - 2006-2015 analysis; 2016-2021 expectations

Oncology drug report - Herceptin - trastuzumab - 2006-2015 analysis; 2016-2021 expectations

  • $ 300
  • Industry report
  • November 2016
  • by Cancer Research Analytics

“Herceptin (trastuzumab): 2006-2015 analysis; 2016-2021 expectations” is a comprehensive report on the second-largest oncology drug by 2015 sales. Herceptin falls in the monoclonal antibody, HER2 inhibitor, ...

Small-Cell Lung Cancer - Pipeline Review, H2 2016

Small-Cell Lung Cancer - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Small-Cell Lung Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Small-Cell Lung Cancer – Pipeline Review, H2 2016, provides ...

Myelodysplastic Syndrome - Pipeline Review, H2 2016

Myelodysplastic Syndrome - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Myelodysplastic Syndrome - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome – Pipeline Review, H2 2016, provides ...

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline ...

Neuroblastoma - Pipeline Review, H2 2016

Neuroblastoma - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Neuroblastoma - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroblastoma – Pipeline Review, H2 2016, provides an overview of ...

Meningioma - Pipeline Review, H2 2016

Meningioma - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Meningioma - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Meningioma – Pipeline Review, H2 2016, provides an overview of the Meningioma ...

Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H2 2016

Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Muscle Invasive Bladder Cancer (MIBC) – Pipeline ...

Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations

Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations

  • $ 1000
  • Industry report
  • November 2016
  • by Cancer Research Analytics

“Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations” is a comprehensive report on Neupogen and Neulasta, two market leading drugs (by ...

Endometrial Cancer - Pipeline Review, H2 2016

Endometrial Cancer - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Endometrial Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Endometrial Cancer – Pipeline Review, H2 2016, provides an overview ...

About 14000 reports for Chemotherapy

Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US

  • January 2014
    186 pages
  • Therapy  

    Chemotherapy  

    Breast Cancer  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.